Cancer clinical trials in the region Bretagne
204 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
#NCT06840483
#2024-517868-33-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
2
3 or more
Hormone therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2
Liver and bile duct cancer
#NCT06330064
#2023-509632-26-00
Hepatocellular carcinoma
Locally Advanced
Metastatic
Unhealthy
A
B
C
1
Immunotherapy
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes)
Daiichi Sankyo
Phase 2
Lung cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT03175224
#2024-514542-37-00
Locally Advanced
Metastatic
MET
1
2
3 or more
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Apollomics
Phase 2
Lymphoma
#NCT04802590
#2024-512634-15-00
B cell lymphoma
Mantel cell lymphoma
None
CD20
> 60 ml/min
50-60 ml/min
None
Systemic Treatment-Naive
Centre Hospitalier Bretagne Atlantique (Vannes), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lung cancer
#NCT05732831
#2022-502645-99-00
SCLC (Small Cell Lung Cancer)
NSCLC (Non-Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Tango Therapeutics
Phase 2
Lung cancer
#NCT06868485
#2024-519713-65-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Wayshine Biopharm, Inc.
Phase 2
Breast cancer
#NCT05955170
#2022-500743-20-00
HER2 Positive
Metastatic
1
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Hôpital Privé des Côtes d'Armor (Plérin)
Institut Curie
Phase 2
Prostate cancer
#NCT06395753
#2024-511038-11-00
Adenocarcinoma
Metastatic Hormone-sensitive
None
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Debiopharm International SA
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05503797
#2024-513578-23-00
Locally Advanced
Metastatic
BRAF
1
2
3 or more
KRAS G12C
KRAS non G12C
NRAS
HRAS
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Fore Biotherapeutics
Phase 2
Lymphoma
#NCT04984837
#2024-513252-15-00
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
Chemotherapy
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Hospitalier Bretagne Atlantique (Vannes), CHU de Rennes - Hôpital Pontchaillou (Rennes)
The Lymphoma Academic Research Organisation (LYSARC)